Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid Organ Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT00004036
What this trial is testing

Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersDrug/Agent Toxicity by Tissue/OrganLeukemia+5 more
The Cleveland Clinic 30
Early research (Phase 1)Study completedNCT01218555
What this trial is testing

Study of Everolimus (RAD001) in Combination With Lenalidomide

Who this might be right for
Solid Organ MalignanciesAdenoidcystic CarcinomaNeuroendocrine Tumors
Emory University 44
Testing effectiveness (Phase 2)Study completedNCT01397929
What this trial is testing

An Open-Label Study of Intravenous BAL101553 in Adult Patients With Solid Tumors

Who this might be right for
Solid Organ Tumors
Basilea Pharmaceutica 73
Not applicableNo Longer AvailableNCT02822495
What this trial is testing

Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies

Who this might be right for
Epstein-Barr Virus (EBV) InfectionsLymphoproliferative DisordersEBV+ Associated Lymphoma+9 more
Atara Biotherapeutics
Large-scale testing (Phase 3)Study completedNCT00003600
What this trial is testing

Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy

Who this might be right for
AnemiaBreast CancerChronic Myeloproliferative Disorders+8 more
Alliance for Clinical Trials in Oncology 344
Testing effectiveness (Phase 2)Active Not RecruitingNCT04349436
What this trial is testing

Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies

Who this might be right for
Merkel Cell CarcinomaBasal Cell CarcinomaLocally Advanced Cutaneous Squamous Cell Carcinoma+1 more
Replimune, Inc. 69
Early research (Phase 1)Looking for participantsNCT03093909
What this trial is testing

Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

Who this might be right for
Malignant Neoplasm of Bone and Articular CartilageMalignant Neoplasms of Female Genital OrgansMalignant Neoplasms of Independent (Primary) Multiple Sites+7 more
M.D. Anderson Cancer Center 44
Post-approval studies (Phase 4)Study completedNCT02866695
What this trial is testing

Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of AK on the Face in Solid Organ Transplant Recipients

Who this might be right for
Actinic Keratosis
University of California, San Francisco 20
Not applicableStudy completedNCT04844489
What this trial is testing

Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People

Who this might be right for
Autoimmune or Autoinflammatory DiseasesHIVMultiple Sclerosis+2 more
Assistance Publique - Hôpitaux de Paris 377
Early research (Phase 1)Study completedNCT00113113
What this trial is testing

Study of Rubitecan in Cancer Patients With Renal or Hepatic Dysfunction

Who this might be right for
Tumors
Astex Pharmaceuticals, Inc. 54
Early research (Phase 1)Study completedNCT00002759
What this trial is testing

Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLymphomaNeutropenia+2 more
National Cancer Institute (NCI) 3
Not applicableEnded earlyNCT01616537
What this trial is testing

Evaluation of Patient Satisfaction With and Acceptance of Their Totally-implanted Central Venous Catheter

Who this might be right for
Malignant Mast Cell TumorsSolid Organ Sites
Centre Antoine Lacassagne 990
Testing effectiveness (Phase 2)Ended earlyNCT00865878
What this trial is testing

ALA-PDT Versus Vehicle PDT for Treatment of AK and Reduction of New NMSC in Solid Organ Transplant Recipients

Who this might be right for
Actinic KeratosesSkin Neoplasms
DUSA Pharmaceuticals, Inc. 6
Not applicableLooking for participantsNCT06792604
What this trial is testing

Host Genome Methylation: a Screening Tool in Anal Cancer Detection

Who this might be right for
Anal Cancer
Assistance Publique - Hôpitaux de Paris 770
Post-approval studies (Phase 4)Looking for participantsNCT07426484
What this trial is testing

Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy

Who this might be right for
Cutaneous Squamous Cell CarcinomaSkin Cancer
Dana-Farber Cancer Institute 80
Early research (Phase 1)UnknownNCT02575638
What this trial is testing

Safety Study of Camptothecin-20-O-Propionate Hydrate (CZ48)

Who this might be right for
Malignant Lymphoma of Extranodal and/or Solid Organ SiteSolid Tumor
Cao Pharmaceuticals Inc. 65
Testing effectiveness (Phase 2)Study completedNCT03345485
What this trial is testing

Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.

Who this might be right for
Small Cell Lung CancerSoft Tissue SarcomaTriple-negative Breast Cancer+2 more
Mundipharma Research Limited 71
Not applicableLooking for participantsNCT07679412
What this trial is testing

Evaluation of Safety and Efficacy of Autologous LB-DTK-CMV in Patients With Antiviral-Resistant and Refractory Cytomegalovirus Retinitis.

Who this might be right for
CMV Retinitis
LucasBio 5
Testing effectiveness (Phase 2)UnknownNCT03769285
What this trial is testing

Skin Cancer Prevention With Nicotinamide in Transplant Recipients - Pilot Trial

Who this might be right for
Non-melanoma Skin CancerCarcinoma, Squamous CellCarcinoma, Basal Cell
Women's College Hospital 120
Large-scale testing (Phase 3)Study completedNCT00296036
What this trial is testing

Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer

Who this might be right for
Breast CancerDrug/Agent Toxicity by Tissue/OrganUnspecified Adult Solid Tumor, Protocol Specific
Alliance for Clinical Trials in Oncology 137
Next Page